RegMed Daily, Closing Bell, 2/23/12, stocks gain but, drifts sideways in thin session
End of Day, Cause and Effect
EOD Commentary: MY … optimism is … breaking and we may be on the verge of a correction. My suspicion is that we’ll see … more than a 10% correction … because of more disappointing economic news overseas and domestically … but, I am further suspicious that the surge … will back off …
Closing Bell: The NASDAQ closed UP +23.81 (+0.81%) to 2,956.98. The Dow closed UP +46.02 (+0.36%) to 12,984.69.
Who’s up … at the close:
- Athersys (ATHX) +$0.07 <+3.65%> to $1.99;
- Brainstorm (OTC BB: BCLI) +$0.03 <+13.04%> to $0.26;
- BioTime (Amex: BTX) +$0.13 <+2.54%> to $5.25;
- Cytomedix (OTC BB: CMXI) +$0.02 <+1.80%> to $1.13;
- Cytori (CYTX) +$0.10 <+3.15%> to $3.27;
- Dendreon (DNDN) +$0.71 <+5.17%> to $14.44;
- Geron (GERN) +$0.11 <+5.61%> to $2.07;
- ImmunoCellular (OTC BB: IMUC) +$0.02<+1.11%> to $1.83;
- Osiris (OSIR) +$0.09 <+1.89%> to $4.89;
- ReNeuron (RENE.L) +$0.01 <+0.12%> to $4.99;
- Verastem (VSTM) +$0.25 <+2.26%> to $11.30.
Categories: RegMed Daily Closing Bell
